FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RC Outsourcing Bevacizumab 1 Recall

Bevacizumab 1

RC Outsourcing, LLC · Lowellville, OH

Risk level
Class II
Reported by FDA
Oct 15, 2025
Recall ID
D-0003-2026
Check your lot numberHow we source this data

Summary

RC Outsourcing recalled Bevacizumab 1 starting Sep 22, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0003-2026 on Oct 15, 2025. Reason: Lack of assurance of sterility. Status: Terminated.

Why it was recalled

Lack of assurance of sterility.

Product description

Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.

Lot numbers, UPCs & expiration codes

Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0003-2026
Classification
Class II
Status
Terminated
Recall initiated
Sep 22, 2025
FDA report date
Oct 15, 2025
Quantity
2,669 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
RC Outsourcing, LLC

Original FDA data

Every field from FDA enforcement report D-0003-2026, exactly as published.

Show all FDA fields
City
Lowellville
State
OH
Status
Terminated
Country
United States
Event ID
97653
Address
102 E Water St
Code information
Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025
Postal code
44436-1117
Report date
Oct 15, 2025
Product type
Drugs
Recall number
D-0003-2026
Classification
Class II
Recalling firm
RC Outsourcing, LLC
Product quantity
2,669 syringes
Termination date
Jan 5, 2026
Reason for recall
Lack of assurance of sterility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
Distribution pattern
Nationwide in the US
Recall initiation date
Sep 22, 2025
Initial firm notification
Letter
Center classification date
Oct 6, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0003-2026, published Oct 15, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls